Business
Manzo Pharmaceuticals begins retail distribution of products with independent pharmacies
Manzo Pharmaceuticals begins retail distribution of products with independent pharmacies.

About this update from Manzo Pharmaceuticals, Inc.
[{"type":"text","content":"\n\n\n\nManzo Pharmaceuticals begins retail distribution of products with independent pharmacies\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nManzo Pharmaceuticals begins retail distribution of products with independent pharmacies\nPR Newswire\nMILFORD, Pa., Nov. 12, 2014\n\n\n\nMILFORD, Pa., Nov. 12, 2014 /PRNewswire/ -- Manzo Pharmaceuticals, Inc. (OTCPink:MNZO), today announced that Manzo's Tummy Relief™ for babies is now being sold at Alitons Pharmacy drug stores in New York and Pennsylvania, and at The Medicine Shoppe in Milford Pennsylvania.  Kenneth Manzo, CEO, stated that this is the beginning stage of promoting his product and is seeking to have it sold by major chain stores.  Although Mr. Manzo already had a relationship with Aliton's, he is also in talks with Walgreens and others to have the product sold through their online properties as well as their brick and mortar locations throughout the United States.\n\nIn addition, Manzo Pharmaceuticals today announced that they are nearing the end of a six month animal study, which tests Lacto-Freedom™, another of the company's products, and the results of the lactase producing probiotic, looks like it'll come to a close successfully. Successful results bring Manzo Pharmaceuticals, and partner, Celprogen, Inc., one step closer to human clinical trials, which will be part of the final preparations for the product's release.\n\nAs stated previously, the 6-month study is being conducted by Celprogen, Inc. using laboratory rats to test the new probiotic treatment. Lab rats are the ideal mammals to test because they are naturally lactose intolerant. After five months the rats given the treatment showed no negative side effects, even at very high doses.  All doses from low to high concentration were very successful at colonizing the intestines and producing lactase, which enabled rats to digest lactose.  This effect lasted for a full five months after the administration of the probiotic was discontinued.  This long lasting residual effect is...